PELLECCHIA, Maria Teresa
 Distribuzione geografica
Continente #
AS - Asia 16.972
NA - Nord America 11.390
EU - Europa 4.888
SA - Sud America 1.298
Continente sconosciuto - Info sul continente non disponibili 632
AF - Africa 159
OC - Oceania 90
Totale 35.429
Nazione #
HK - Hong Kong 11.147
US - Stati Uniti d'America 11.060
SG - Singapore 2.571
IT - Italia 2.057
CN - Cina 1.207
BR - Brasile 956
VN - Vietnam 896
RU - Federazione Russa 538
UA - Ucraina 531
DE - Germania 365
IE - Irlanda 291
FR - Francia 250
KR - Corea 206
TR - Turchia 199
SE - Svezia 195
BD - Bangladesh 181
CA - Canada 160
GB - Regno Unito 159
IN - India 159
FI - Finlandia 140
AR - Argentina 127
MX - Messico 80
JP - Giappone 76
PL - Polonia 63
NL - Olanda 57
AU - Australia 49
CO - Colombia 49
EC - Ecuador 47
IQ - Iraq 46
AT - Austria 45
EE - Estonia 38
ZA - Sudafrica 38
NZ - Nuova Zelanda 37
ES - Italia 35
ID - Indonesia 35
PK - Pakistan 35
CZ - Repubblica Ceca 33
VE - Venezuela 33
CL - Cile 26
UZ - Uzbekistan 25
JM - Giamaica 24
KE - Kenya 22
PE - Perù 22
MA - Marocco 21
IL - Israele 20
PH - Filippine 20
SA - Arabia Saudita 20
PY - Paraguay 18
MY - Malesia 15
CR - Costa Rica 13
JO - Giordania 12
TN - Tunisia 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EG - Egitto 10
ET - Etiopia 10
UY - Uruguay 10
AZ - Azerbaigian 9
BO - Bolivia 9
HN - Honduras 9
LB - Libano 9
OM - Oman 9
DZ - Algeria 8
KZ - Kazakistan 8
BE - Belgio 7
DO - Repubblica Dominicana 7
NP - Nepal 7
AL - Albania 6
GR - Grecia 6
NI - Nicaragua 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BW - Botswana 5
CY - Cipro 5
GT - Guatemala 5
KG - Kirghizistan 5
KH - Cambogia 5
PT - Portogallo 5
TW - Taiwan 5
LK - Sri Lanka 4
LU - Lussemburgo 4
MN - Mongolia 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
BS - Bahamas 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GE - Georgia 3
IR - Iran 3
LV - Lettonia 3
LY - Libia 3
MD - Moldavia 3
MK - Macedonia 3
PS - Palestinian Territory 3
RO - Romania 3
Totale 34.736
Città #
Hong Kong 11.128
Ann Arbor 1.422
Singapore 1.234
San Jose 1.220
Milan 771
Chandler 732
Princeton 708
Ashburn 703
Wilmington 666
Jacksonville 662
Dallas 541
Council Bluffs 325
Beijing 313
Dublin 279
Dong Ket 270
Houston 235
Woodbridge 234
The Dalles 223
Ho Chi Minh City 214
Lauterbourg 213
Rome 189
Los Angeles 166
Nanjing 156
Izmir 154
New York 149
Moscow 148
Santa Clara 144
Hanoi 142
Andover 141
Naples 132
Boardman 128
Pellezzano 109
Dearborn 93
Salerno 90
São Paulo 89
Figino 77
Tokyo 69
Buffalo 67
Norwalk 59
Düsseldorf 55
Munich 55
Fairfield 54
Montreal 53
Frankfurt am Main 51
Nanchang 49
Changsha 47
Hebei 46
Memphis 46
Shenyang 45
Turin 45
Warsaw 45
Redwood City 41
Brooklyn 40
Tallinn 38
San Francisco 37
Chicago 36
Jiaxing 36
Nuremberg 36
Pune 35
Da Nang 34
Orem 34
Rio de Janeiro 33
Atlanta 31
Seattle 30
Phoenix 29
Haiphong 28
Belo Horizonte 27
Chennai 27
Mestre 27
Denver 26
Amsterdam 25
Boston 25
Washington 24
Seoul 22
Brasília 21
Brno 21
Johannesburg 21
London 21
Tashkent 21
West Jordan 21
Bologna 20
Curitiba 20
Mexico City 20
Stockholm 20
Nairobi 19
Columbus 18
Buenos Aires 17
Poplar 17
Shanghai 17
Turku 17
Auckland 16
Baghdad 16
Charlotte 16
Guayaquil 16
Helsinki 16
Porto Alegre 16
San Diego 16
Tianjin 16
Guarulhos 15
Kingston 15
Totale 26.176
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.198
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.054
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 969
Sex Differences in Parkinson’s Disease: From Bench to Bedside 653
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 603
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 599
Gender differences in microRNA expression in levodopa-naive PD patients 580
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 549
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 535
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 519
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 472
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 396
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 381
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 362
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 361
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 342
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 333
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 329
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 322
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 317
A novel phenotype in an Italian family with a rare progranulin mutation 313
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 280
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 277
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 249
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 226
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 223
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 218
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 215
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 210
The natural history of multiple system atrophy: A prospective European cohort study 205
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 204
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 201
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 200
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 194
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 193
Postganglionic sudomotor denervation in patients with multiple system atrophy. 190
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 188
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 186
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 186
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 183
A critique of the second consensus criteria for multiple system atrophy 180
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 176
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 172
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 170
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 170
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 166
Brain anatomical substrates of mirror movements in Kallmann syndrome. 162
Quitting smoking: An early non-motor feature of Parkinson's disease? 157
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 155
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 154
Increased bilirubin levels in de novo Parkinson's disease 152
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 149
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 149
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 149
Sindromi parkinsoniane 145
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 145
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 144
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 142
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 142
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 141
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 139
The relevance of gender in Parkinson's disease: a review 138
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 136
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 136
A genome-wide association study in multiple system atrophy 136
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 136
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 134
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 134
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 133
The alpha-synuclein gene in multiple system atrophy 132
The accuracy of the arginine growth hormone test in parkinsonism. 129
Cognitive correlates of “pure apathy” in Parkinson's disease 129
Gender and non motor fluctuations in Parkinson's disease: A prospective study 128
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 128
Early MRI findings in acquired hepatocerebral degeneration. 126
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 126
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 125
PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts 125
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 124
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 123
Cross-modal connectivity effects in age-related hearing loss 122
SNCA variants are associated with increased risk for multiple system atrophy 121
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 121
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 120
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 120
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 120
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 118
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 118
“Response to Apomorphine in early Parkinson’s disease”. 118
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 118
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 117
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 117
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease 117
A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy 116
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 116
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 115
Uric acid relates to dopamine transporter availability in Parkinson's disease. 114
On the relationship between side of onset and cognition in Parkinson disease 114
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 114
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 113
Totale 23.301
Categoria #
all - tutte 108.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.107 0 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202621.068 3.032 5.189 4.284 697 1.263 609 1.844 420 606 1.158 405 1.561
2026/2027911 672 239 0 0 0 0 0 0 0 0 0 0
Totale 35.429